BRAIN Biotech AG (ETR:BNN)
Germany · Delayed Price · Currency is EUR 2.720
-0.060 (-2.16%)
Jul 28, 2026, 9:59 AM CET
BRAIN Biotech AG Financials Overview
Financials in millions EUR. Fiscal year is October - September.
Millions EUR. Fiscal year is Oct - Sep.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Revenue Revenue Growth | 48.31 | 50.22 | 55.5 | 56.23 | 50.3 | 39.22 |
Revenue Growth | -9.73% | -9.52% | -1.29% | 11.79% | 28.23% | 0.40% |
Gross Profit Gross Profit Growth | 28.01 | 28.1 | 30.56 | 30.42 | 27.61 | 21.82 |
Operating Income Operating Income Growth | -7.58 | -7.76 | -9.01 | -5.56 | -6.38 | -7.39 |
Net Income Net Income Growth | -11.02 | -11.74 | -11.13 | -8.28 | -6.59 | -4.97 |
Earnings Per Share EPS Growth | -0.51 | -0.54 | -0.51 | -0.38 | -0.30 | -0.25 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Brainbiocatalysts Brainbiocatalysts Growth | 43.39 | 45.8 | 47.81 | - | - | - |
BRAINBioincubator BRAINBioincubator Growth | 4.92 | 4.41 | 7.89 | 0.94 | 0.11 | - |
Reconciliation Reconciliation Growth | - | - | -0.19 | -0.04 | -0.12 | -0.16 |
Total Total Growth | 48.31 | 50.22 | 55.5 | 56.23 | 50.3 | 39.22 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Cash & Investments Cash & Investments Growth | 4.26 | 6.32 | 27.23 | 5.41 | 8.53 | 24.6 |
Total Debt Total Debt Growth | 6.99 | 20.73 | 26.3 | 10.44 | 10.74 | 11.38 |
Net Cash (Debt) Net Cash Growth | -2.73 | -14.42 | 0.93 | -5.03 | -2.21 | 13.22 |
Net Cash Growth | - | - | - | - | - | 123.82% |
Net Cash Per Share Net Cash Per Share Growth | -0.12 | -0.66 | 0.04 | -0.23 | -0.10 | 0.66 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -5.61 | -9.23 | -3.58 | -4.22 | -1.49 | -3.91 |
Capital Expenditures CapEx Growth | -2.05 | -1.53 | -1.55 | -2.62 | -5.8 | -1.25 |
Free Cash Flow Free Cash Flow Growth | -7.65 | -10.77 | -5.14 | -6.84 | -7.29 | -5.16 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Gross Margin | 57.97% | 55.95% | 55.07% | 54.11% | 54.89% | 55.63% |
Operating Margin | -15.69% | -15.45% | -16.24% | -9.89% | -12.69% | -18.84% |
Pretax Margin | -23.47% | -23.94% | -19.80% | -13.32% | -12.26% | -10.90% |
Profit Margin | -22.81% | -23.38% | -20.05% | -14.72% | -13.10% | -12.68% |
FCF Margin | -15.83% | -21.44% | -9.25% | -12.16% | -14.49% | -13.15% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 28, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Forward PE | - | 235.00 | 235.00 | 235.00 | 235.00 | 235.00 |
PS Ratio | 1.26 | 0.95 | 0.84 | 1.65 | 1.92 | 5.63 |